Biohacking & Life Tracking

D&I webinar series

Webinar
tiistai 23.11.2021
klo 9.00 – 10.00
Tiedustelut:
[email protected]

D&I Innovation Powerhouse webinar:

Biohacking & Life Tracking – miten terveystiedoista luodaan vastuullista liiketoimintaa

D&I Innovation Powerhousen  webinaarisarjan syksyn viimeisessä osassa tarkastelemme, miten kuluttajan itsestään keräämistä tiedoista, erityisesti terveystiedoista, luodaan vastuullista liiketoimintaa.

Webinaarissa Juli Mansnérus, Iiris Kivikari ja Mirva Arvola kertovat, minkälaista juridiikkaa biohakkerointi ja kehonmittaus kätkevät sisäänsä ja mitä yritysten tulisi ottaa huomioon hyödyntäessään tällaista tietoa esimerkiksi tuotekehityksessään, kuluttajapalveluiden tarjoamisessa taikka tieteellisessä tutkimuksessa.

Pureudumme myös yrityskaupan jälkeiseen tiedon uudelleen järjestelyyn ja terveysdatan käytön kilpailuoikeudellisiin puoliin muun muassa Euroopan komission Google/Fitbit-tapauksen kautta.

Jos et ole saanut kutsua tilaisuuteen ja haluaisit osallistua, voit olla yhteydessä:
[email protected]
Tilaisuutemme ovat ensisijaisesti tarkoitettu asiakkaillemme ja muille sidosryhmillemme.

 

In D&I Innovation Powerhouse’s webinar series our lawyers address topical issues such as cooperation with authorities, legislation of AI-technologies and development, regulation, data transfers and reporting to the company executives.

More by the same author

The EU’s Pharmaceutical Legislation Reform

The European Union’s imminent pharmaceutical legislation reform aims to modernise its regulatory framework, focusing on improving patient access to medicines, fostering innovation, and minimising environmental impact. This strategic overhaul, set against a backdrop of industry challenges and evolving IP rights, underscores the EU’s commitment to balancing innovation with accessibility and sustainability in healthcare.

The European Parliament and the Council reach an agreement on European Health Data Space!

Towards a stronger European Health Union On March 15, 2024, the European Parliament and the Belgian Presidency of the Council reached a provisional political agreement on the European Health Data Space (EHDS) which is considered one of the central building blocks towards a stronger European Health Union. The upcoming EHDS aims to harness the full potential offered by the sharing, use, and re-use of health data, while ensuring full compliance with the data protection standards in the EU. This marks a significant milestone in the EU’s health data regulation.

Ready or Not, Here Comes the AI Act!

D&I’s summary of the changes coming your way The European Parliament has approved the Artificial Intelligence Act on 13 March 2024. The AI Act is a huge step forward in creating a legal framework for AI technology throughout the European Union. It brings about substantial new obligations for both the developers and users of artificial intelligence (or, using the terminology of the Act itself, the providers, importers, deployers, authorised representatives and other parties listed in the Act). However, although the categorisation does cut a few corners, the AI Act can be seen as a type of “product safety” legislation. As such, it leaves a wide range of topics to be dealt with in other EU and/or national laws, or by the parties involved in a specific transaction.

Latest insights

Are Finnish Lawyers the Happiest in the World?

Article / 4 Apr 2024
Reading time 2 minutes

Implementing the Data Act without Clashing with the GDPR?

Article / 4 Apr 2024